Why the study?
Distinguishing between athlete's heart and hypertension can be challenging because exercise-induced cardiac remodelling may mimic the pathological remodelling of pathological hypertrophy.
How can clinicians differentiate between hypertensive heart disease and physiological athlete's heart in competitive athletes with left ventricular hypertrophy?
How can clinicians differentiate between hypertensive heart disease and physiological athlete's heart in competitive athletes with left ventricular hypertrophy?
This review provides clinical guidance on differentiating physiological athlete's heart from pathological hypertensive heart disease, which is crucial for the appropriate management of athletes.
May inform LVH differentiation in athletes; leaves open prospective validation.
Athlete's heart is typically accompanied by a remodelling of the cardiac chambers induced by exercise. However, although competitive athletes are commonly considered healthy, they can be affected by cardiac disorders characterised by an increase in left ventricular mass and wall thickness, such as hypertension. Unfortunately, training-induced increase in left ventricular mass, wall thickness, and atrial and ventricular dilatation observed in competitive athletes may mimic the pathological remodelling of pathological hypertrophy. As a consequence, distinguishing between athlete's heart and hypertension can sometimes be challenging. The present review aimed to focus on the differential diagnosis between hypertensive heart disease and athlete's heart, providing clinical information useful to distinguish between physiological and pathological remodelling.
No takes yet. Share an insight, caveat, or question.
D’Ascenzi et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: